Cathy Dantzman

Person

Delaware, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)...
- Patent number 7,977,355
- Issue date Jul 12, 2011
- Astrazeneca AB
- Megan Murphy King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)...
- Patent number 7,659,286
- Issue date Feb 9, 2010
- Astrazeneca AB
- Cathy Dantzman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and...
- Patent number 7,368,448
- Issue date May 6, 2008
- Astrazeneca AB
- Cathy Dantzman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and method for the treatment of overactive bladder
- Patent number 7,368,461
- Issue date May 6, 2008
- Astrazeneca AB
- Russell Bialecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective estrogen receptor-β ligands
- Patent number 7,256,201
- Issue date Aug 14, 2007
- Astrazeneca AB
- Bernard Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic benzoxazole compounds
- Patent number 7,045,539
- Issue date May 16, 2006
- Astrazeneca AB
- Bernard Barlaam
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)...
- Publication number 20100160374
- Publication date Jun 24, 2010
- AstraZeneca AB
- Khanh Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor M...
- Publication number 20090012127
- Publication date Jan 8, 2009
- AstraZeneca AB
- Thomas R. Simpson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(Arylalkoxy)-1-Phenylethylamine Derivatives As NK1 Antagonist And...
- Publication number 20080234282
- Publication date Sep 25, 2008
- AstraZeneca AB
- Cathy Dantzman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)...
- Publication number 20080182875
- Publication date Jul 31, 2008
- AstraZeneca AB
- Khanh Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ER-beta-selective ligands
- Publication number 20070208066
- Publication date Sep 6, 2007
- Bernard Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And S...
- Publication number 20070203139
- Publication date Aug 30, 2007
- AstraZeneca AB
- Peter Bernstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and...
- Publication number 20070185127
- Publication date Aug 9, 2007
- AstraZeneca AB
- Cathy Dantzman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Naphthamide derivatives and their use
- Publication number 20060241142
- Publication date Oct 26, 2006
- Aleatel Wireless, Inc.
- Peter Bernstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic benzothiazole compounds
- Publication number 20060111408
- Publication date May 25, 2006
- Bernard Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and method for the treatment of overactive bladder
- Publication number 20050203113
- Publication date Sep 15, 2005
- Russell Bialecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective estrogen receptor-beta ligands
- Publication number 20050101584
- Publication date May 12, 2005
- Bernard Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for the treatment of overactive bladder
- Publication number 20040248914
- Publication date Dec 9, 2004
- Russell Bialecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic compounds
- Publication number 20040102435
- Publication date May 27, 2004
- Bernard Barlaam
- C07 - ORGANIC CHEMISTRY

Cathy Dantzman

Person

Patents Grantslast 30 patents

N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)...

N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)...

2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and...

Compounds and method for the treatment of overactive bladder

Selective estrogen receptor-β ligands

Therapeutic benzoxazole compounds

Patents Applicationslast 30 patents

N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)...

Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor M...

2-(Arylalkoxy)-1-Phenylethylamine Derivatives As NK1 Antagonist And...

N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)...

ER-beta-selective ligands

Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And S...

2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and...

Naphthamide derivatives and their use

Therapeutic benzothiazole compounds

Compounds and method for the treatment of overactive bladder

Selective estrogen receptor-beta ligands

Method for the treatment of overactive bladder

Therapeutic compounds